Toxoplasmosis laboratory findings

Jump to navigation Jump to search

Toxoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxoplasmosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxoplasmosis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxoplasmosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxoplasmosis laboratory findings

CDC on Toxoplasmosis laboratory findings

Toxoplasmosis laboratory findings in the news

Blogs on Toxoplasmosis laboratory findings

Directions to Hospitals Treating Toxoplasmosis

Risk calculators and risk factors for Toxoplasmosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Toxoplasma infection is diagnosed by the presence of parasite in the fluids such as blood, body fluids, or tissue by DNA amplification, microscopy or by isolation of the organism. The most commonly used diagnostic test is the PCR of the amniotic fluid and a positive test is diagnostic of congenital toxoplasmosis.[1]

Laboratory Findings

Initial tests

Serological tests Anti-Toxoplasma IgG
Anti-Toxoplasma IgM

Interpretation of Serological Tests

 
 
 
 
 
 
IgG/IgM(ideally performed in the first trimester
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Negative IgG and IgM
 
Positive IgG
Negative IgM
 
Positive IgM
Negative IgG
 
Positive IgG and IgM
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ No serologic evidence of Toxoplasma infection
❑ Risk of congenital Toxoplasmosis only if the woman aquires infection during the pregnancy
❑ Counsel about the preventive measures for T.gondii
 
<18 weeks of gestation Infection aquired in the past and prior to the pregnancy
❑ Risk of infection is zero unless the patient is immunocompromised
≥18 weeks of gestation
❑ It is difficult to establish the timing of infection
 
Repeat IgG and IgM in 1 to 3weeks
 
Serum should be sent to reference laboratory for confirmatory testing
❑ If the confirmatory test is positive initiate treatment and if negative follow up for 12 months
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Follow up testing is indicated during gestation to detect seroconversion
 
≤ 18 weeks of gestation
❑ No further action indicated
>18 weeks of gestation
❑ Compare to previous serological tests and send samples to a reference laboratory to confirm the timing of infection
 
Negative IgG and Positive IgM
❑ Does not have clinical relevance[2]
 
 
 
 
 
 
 
 
 
Positive IgG and IgM
❑ Seroconverted and fetus is at risk
❑ Initiate treatment and consider PCR
 
 
 
 
 
 

Table adopted from Management of Toxoplasma gondii Infection during Pregnancy[3]

Microscopy

A: Toxoplasma gondii tachyzoites, stained with Giemsa, from a smear of peritoneal fluid obtained from a mouse inoculated with T. gondii. Tachyzoites are typically crescent shaped with a prominent, centrally placed nucleus.

Toxoplasma gondii tachyzoites, stained with Giemsa
Toxoplasma gondii tachyzoites, stained with Giemsa


B: Toxoplasma gondii cyst in brain tissue stained with hematoxylin and eosin (100×). C: Zoom of Image B, T. gondii cyst.

Toxoplasma gondii cyst, hematoxylin and eosin stain
Toxoplasma gondii cyst, hematoxylin and eosin stain


References

  1. Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A; et al. (1999). "Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters". Am J Obstet Gynecol. 181 (4): 843–7. PMID 10521739.
  2. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K; et al. (1997). "False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test". J Clin Microbiol. 35 (1): 174–8. PMC 229533. PMID 8968902.
  3. Montoya, Jose G.; Remington, Jack S. (2008). "Clinical Practice: Management ofToxoplasma gondiiInfection during Pregnancy". Clinical Infectious Diseases. 47 (4): 554–566. doi:10.1086/590149. ISSN 1058-4838.


Template:WikiDoc Sources